News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,910 Results
Type
Article (8017)
Company Profile (140)
Press Release (476752)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166765)
Career Advice (305)
Deals (25740)
Drug Delivery (7)
Drug Development (52876)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238251)
Policy (17923)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (105)
Alzheimer's disease (978)
Antibody-drug conjugate (ADC) (270)
Approvals (10387)
Artificial intelligence (323)
ASCO (159)
Autoimmune disease (206)
Automation (28)
Bankruptcy (263)
Best Places to Work (6958)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (110)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (29)
Breast cancer (512)
Cancer (3672)
Cardiovascular disease (220)
Career advice (245)
Career pathing (1)
CAR-T (174)
CDMO (7)
Celiac Disease (1)
Cell therapy (478)
Cervical cancer (34)
Clinical research (47904)
Collaboration (1252)
Commercialization (3)
Compensation (1473)
Complete response letters (34)
COVID-19 (756)
CRISPR (63)
C-suite (757)
Cystic fibrosis (85)
Data (5691)
Denatured (4)
Depression (102)
Dermatology (63)
Diabetes (344)
Diagnostics (4191)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (156)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73726)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87676)
Executive appointments (702)
FDA (12417)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (925)
Gene editing (125)
Generative AI (9)
Gene therapy (319)
GLP-1 (290)
Government (943)
Grass and pollen (2)
Guidances (281)
Healthcare (9327)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (57)
Indications (157)
Infectious disease (944)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (258)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (10)
Liver cancer (44)
Longevity (18)
Lung cancer (511)
Lymphoma (253)
Machine learning (27)
Management (3)
Manufacturing (537)
Marketing (8)
MASH (118)
Medical device (8662)
Medtech (8809)
Mergers & acquisitions (14388)
Metabolic disorders (709)
mRNA (59)
Multiple sclerosis (103)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (40)
Neuroscience (1833)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (225)
Opinion (10)
Ovarian cancer (159)
Pain (172)
Pancreatic cancer (200)
Parkinson's disease (201)
Partnered (12)
Patents (479)
Patient recruitment (512)
Peanut (31)
People (41258)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15474)
Phase 2 (21390)
Phase 3 (14418)
Pipeline (7410)
Policy (18)
Postmarket research (1570)
Preclinical (6540)
Press Release (34)
Prostate cancer (191)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (576)
Real estate (3019)
Recruiting (6)
Regulatory (14856)
Reports (21)
Research institute (582)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (101)
Series A (156)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (330)
Venture capital (17)
Weight loss (73)
Women's health (81)
Date
Last 7 days (241)
Last 30 days (1425)
Last 365 days (18883)
2026 (12535)
2025 (19252)
2024 (22986)
2023 (26542)
2022 (34587)
2021 (37167)
2020 (33471)
2019 (23257)
2018 (17495)
2017 (18767)
2016 (17921)
2015 (24263)
2014 (21679)
2013 (18136)
2012 (20221)
2011 (20440)
2010 (20333)
Location
Africa (228)
Alabama (74)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17911)
Australia (2099)
California (12037)
Canada (3163)
China (528)
Colorado (486)
Connecticut (413)
Delaware (208)
Europe (24641)
Florida (1801)
Georgia (385)
Hawaii (3)
Idaho (46)
Illinois (705)
India (51)
Indiana (315)
Iowa (15)
Japan (409)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1206)
Massachusetts (7886)
Michigan (308)
Minnesota (563)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2632)
New Mexico (12)
New York (2826)
North Carolina (1288)
North Dakota (4)
Northern California (6035)
Ohio (280)
Oklahoma (14)
Oregon (16)
Pennsylvania (2262)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5002)
Tennessee (120)
Texas (1955)
United States (39062)
Utah (362)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (932)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
484,910 Results for "pharmascience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharmascience Canada announces the launch of ᴾʳpms-DOLUTEGRAVIR
April 29, 2026
·
1 min read
Press Releases
Pharmascience Announces the Appointment of Jim Vounassis as Chief Executive Officer
November 20, 2025
·
2 min read
Business
Pharmascience Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Montreal, Quebec--(Newsfile Corp. - April 3, 2024) - Pharmascience Inc., the largest Canadian-owned pharmaceutical company and a leader in the Canadian generic market, will be participating in the 2024 Bloom Burton & Co
April 3, 2024
·
2 min read
Press Releases
Pharmascience Canada strengthens its commitment to patients with an antihistamine treatment
February 9, 2025
·
2 min read
Pharmascience Expands its Contract Development and Manufacturing Organization (CDMO) Services With a New Commercial Business Unit
Last Fall, Pharmascience, the largest Canadian-owned pharmaceutical company, announced a major $120 million sterile injectable manufacturing facility expansion at its Candiac site.
February 26, 2024
·
3 min read
Press Releases
Pharmascience Canada launches Pr pms-PALBOCICLIB, a treatment for breast cancer
November 27, 2024
·
2 min read
Pharmascience Canada Launches an Extension to its New Methotrexate Product Line: pms-METHOTREXATE INJECTION 50mg/ml
Pharmascience Canada is proud to announce the launch of pms- METHOTREXATE INJECTION (methotrexate injection) 50 mg/ml, a drug indicated for the treatment of psoriasis, psoriatic arthritis and rheumatoid arthritis in adults aged 18 to 65 with severe disabling conditions, when other treatments do not work.
March 15, 2024
·
2 min read
BioMidwest
Infinity Laboratories Unveils New Brand at AAPS 2023 PharmaSci 360 in Orlando, FL
Infinity Laboratories is thrilled to officially unveil its new brand identity at the AAPS 2023 PharmaSci 360 Annual Meeting from October 22nd to the 25th in Orlando, Florida.
October 23, 2023
·
2 min read
Business
PHARMASCIENCE INC. ANNOUNCES APPOINTMENT OF MARTIN ARES AS NEW CHIEF EXECUTIVE OFFICER
Pharmascience Inc. is pleased to announce today the appointment of Martin Arès as Chief Executive Officer, effective January 3, 2023.
November 16, 2022
·
2 min read
Pharmascience Canada launches another generic drug with multiple indications
Pharmascience Canada launches the generic Prpms-TOFACITINIB in the Canadian market, last November 2022.
January 16, 2023
·
2 min read
1 of 48,491
Next
